SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028783
Filing Date
2023-06-20
Accepted
2023-06-20 08:00:54
Documents
12
Period of Report
2023-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K fusn-20230614.htm   iXBRL 8-K 115255
  Complete submission text file 0000950170-23-028783.txt   244652

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fusn-20230614.xsd EX-101.SCH 2474
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fusn-20230614_pre.xml EX-101.PRE 11545
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fusn-20230614_lab.xml EX-101.LAB 18645
6 EXTRACTED XBRL INSTANCE DOCUMENT fusn-20230614_htm.xml XML 4873
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 231023436
SIC: 2836 Biological Products, (No Diagnostic Substances)